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Abstract
The diathesis-stress model of psychiatric conditions has recently been challenged by the view that it might be
more accurate to speak of ‘differential susceptibility’ or ‘plasticity’ genes, rather than one-sidedly focusing on
individual vulnerability. That is, the same allelic variation that predisposes to a psychiatric disorder if associated with
(developmentally early) environmental adversity may lead to a better-than-average functional outcome in the same
domain under thriving (or favourable) environmental conditions. Studies of polymorphic variations of the serotonin
transporter gene, the monoamino-oxidase-inhibitor A coding gene or the dopamine D4 receptor gene indicate
that the early environment plays a crucial role in the development of favourable versus unfavourable outcomes.
Current evidence is limited, however, to establishing a link between genetic variation and behavioural phenotypes.
In contrast, little is known about how plasticity may be expressed at the neuroanatomical level as a ‘hard-wired’
correlate of observable behaviour. The present review article seeks to further strengthen the argument in favour of
the differential susceptibility theory by incorporating findings from behavioural and neuroanatomical studies in
relation to genetic variation of the oxytocin receptor gene. It is suggested that polymorphic variation at the
oxytocin receptor gene (rs2254298) is associated with sociability, amygdala volume and differential risk for
psychiatric conditions including autism, depression and anxiety disorder, depending on the quality of early
environmental experiences. Seeing genetic variation at the core of developmental plasticity can explain, in contrast
to the diathesis-stress perspective, why evolution by natural selection has maintained such ‘risk’ alleles in the gene
pool of a population.
Please see related manuscript: http://www.biomedcentral.com/1741-7015/10/37
Background
The idea that individuals are at elevated risk of develop-
ing a psychopathological condition due to their genetic
make-up, particularly when exposed to adverse environ-
mental conditions, known as the diathesis-stress model
[1], has become the prevailing theoretical concept in
psychiatry. The model further entails that people who
do not carry ‘vulnerability genes’ are less susceptible to
adversity. One of the most widely cited examples of
gene-environment-interaction was published by Caspi
et al. [2] who demonstrated that persons carrying the
low-activity variant of the monoamine oxidase A
(MAO-A) enzyme are more likely to develop antisocial
personality disorder under adverse environmental condi-
tions during childhood compared to individuals endowed
with the high-activity allele. Put differently, subjects who
degrade biogenic amines like dopamine and noradrenaline
slowly are more vulnerable to develop, as children, atten-
tion-deficit hyperactivity disorder (ADHD) and conduct
disorder, and, as adults, antisocial personality disorder
when having suffered early adversity such as maltreatment
or abuse. Conversely, it has been argued that the absence
of adversity has the potential to compensate the genetic
vulnerability, also known as ‘maternal buffering’ [3]. Other
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examples of gene-environment interaction include the s-
allele of the serotonin transporter gene (5-HTTLPR),
which predisposes to depression if accompanied by stress-
ful life-events [4], and the seven-repeat variant of the
dopamine receptor D4 gene (DRD4), which increases the
vulnerability for externalizing problems and ADHD in
children whose mothers are insensitive to their children’s
needs [5].
While it is indisputable that this line of research has
greatly advanced our understanding of the role of gene-
environment interaction in psychopathology, the diathesis-
stress model, as currently conceived, falls short of explain-
ing why many of these vulnerability genes have undergone
recent positive selection in human evolution, because it is
implausible to assume that natural selection has favoured
allelic variants only to increase one’s vulnerability to adver-
sity. In other words, there must be a flipside of the coin.
Evidence from cross-cultural genetic studies suggests,
for example, that the seven-repeat variant of the DRD4
gene emerged some 50,000 years ago in human popula-
tions, whereas the four-repeat variant is the ancestral
version of this gene [6]. The seven-repeat allele has repeti-
tively (though inconsistently) been associated with the per-
sonality trait ‘novelty seeking’, a human attribute that
arguably may have conferred a reproductive advantage in
recent human history [7,8]. Similarly, Lesch and colleagues
have shown that, while carrying the s-allele of the
HTTLPR predisposes to depression if associated with
adverse events, the same variation is linked to superior
cognitive performance in several domains and increases
social conformity [9,10]. The latter example is prototypical
for a ‘balanced polymorphism’, that is, a single nucleotide
polymorphism (SNP) may exert disadvantageous effects in
one domain, which are compensated by advantageous
effects in another domain. A balanced polymorphism also
explains the frequency of a particular SNP in the general
population, and why it has not been selected against.
Balanced polymorphisms are, however, implausible to
account for those cases in which the compensatory effect
happens to occur in the same domain. Instead, Belsky
[11] has argued from an evolutionary point of view that a
particular genetic variation that predisposes to pathology
if associated with early adversity can have beneficial
effects when environmental contingencies are develop-
mentally more positive. To this end, Belsky et al. [12]
have highlighted a methodological problem that is notor-
iously prevalent in most gene-environment-interaction
studies. They argued that ‘simply treating the absence
of adversity as the “good” end of the environmental-
exposure continuum and/or absence of a disorder as the
“good” end of the psychological functioning continuum
may lead to the under-detection of differential suscept-
ibility [this author’s emphasis] findings and an over
representation of vulnerability ones.’ Accordingly, they
proposed that it is necessary to inquire whether the same
genes that convey increased vulnerability to psycho-
pathology under adverse environmental conditions have
the potential to act in advantageous ways on psychologi-
cal functioning when the environment is supportive or
enriched [12]. Put another way, it may be more accurate
to speak of differential susceptibility or plasticity con-
ferred by genetic variation - that is, responsivity to both
positive and negative conditions - rather than focusing
one-sidedly on vulnerability [13].
In support of this ground-breaking and novel concep-
tualization, it has been demonstrated that the low-activity
MAO-A variant is associated with lower than average pre-
valence of antisocial personality when children grow up in
supportive environments [14]. Likewise, the s-allele of the
5-HTTLPR confers a lower risk for depression under
favourable environmental conditions [15], and children
carrying the seven-repeat variant of the DRD4 gene
develop ADHD and externalizing problems less than aver-
age if their mothers behave in responsive ways to their
children’s needs [5].
The potential impact of this new perspective on gene-
environment interaction and behavioural consequences, as
far as psychopathological conditions are concerned, can
hardly be over-estimated. At present, this approach has
only been linked to the behavioural phenotype and not to
the neuroanatomical correlates on which putative plasti-
city genes can also operate. If it is possible to demonstrate,
however, that plasticity genes convey differential effects on
both behaviour and matching neuroanatomical structures,
the model would support the claim that the diathesis-
stress concept should be refined in the direction outlined
above.
Accordingly, this article seeks to explore the differential
impact of genetic variation on behaviour and underlying
anatomical structures, exemplified by a polymorphic varia-
tion (rs2254298) of the oxytocin receptor gene (OXTR).
This SNP of the OXTR was chosen for several reasons.
First, research on human social behaviour suggests that
natural selection has favoured the processing of social
information in primates, including humans, which culmi-
nates in the detection of intentions and dispositions of
conspecifics (members of the same species). This key con-
cept of human brain evolution, referred to as the ‘social
brain’ hypothesis [16], proposes that a major driving force
that ultimately led to the evolution of large hominid brains
was the increasing complexity of ancestral social environ-
ments [17]. Oxytocin (OXT) is an evolutionarily conserved
hormone that is critically involved in regulating social
behaviour such as social recognition, mating, attachment
and caring for offspring in virtually all mammalian species
[18]. In support of this notion, recent studies have discov-
ered that the administration of OXT has the potential to
increase social (re)-cognition in humans [19,20], and even
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to partially restore impaired social cognition in neuropsy-
chiatric disorders [21,22]. Moreover, evidence is accumu-
lating that polymorphic variation of the OXTR impacts on
attachment-related behaviour and social cognition in
humans [23,24].
Secondly, The SNP rs2254298 of OXTR has been stu-
died considerably with regard to its impact on various psy-
chological dimensions, such as affect and temperament. In
addition, this SNP is the only one at OXTR for which
information on the interaction between genetic variation,
attachment and the quality of early childhood experiences
is available. Moreover, the SNP rs2254298 has been stu-
died as regards neuroanatomical correlates of social cogni-
tion, and has undergone recent evolutionary change. All of
these factors render this SNP of OXTR unique to address
the question as to whether or not it could represent a can-
didate for the differential susceptibility hypothesis.
This article is organized as follows: first, it summarizes
the effects of OXT on social cognition and the role of
OXT in psychopathological conditions. Second, it high-
lights the findings of studies that have specifically dealt
with the SNP rs2254298 of OXTR as far as psychological
dimensions, attachment and neuroanatomy are concerned.
Third, the implications (as well as limitations) of these
findings for the differential susceptibility hypothesis with
regard to rs2254298 are discussed. The article concludes
with some ideas for future directions and research.
Oxytocin, social cognition and psychopathology
For decades, OXT was best known in medicine for its role
in parturition and lactation. Only recently, OXT has been
intensely investigated for its potential impact on psycholo-
gical dimensions such as social attachment and cognition
[19]. In addition, OXT has become a target of clinically
motivated research, particularly concerning its relationship
to vulnerability to disorder and treatment of psychiatric
disorders [21,22]. Consequently, based on observations
that intranasal application of supra-physiological dosages
of OXT improves ‘mindreading’ abilities [25], fear recogni-
tion [26] and trust in healthy subjects [27,28], as well as
studies demonstrating the role of OXT in establishing
secure attachment and bonding [29,30], research on the
effect of OXT on psychopathological parameters and cog-
nition in adult psychiatric disorders has seen a recent
resurgence after a long period of lying dormant.
It was shown in the early 1970s that OXT has the poten-
tial to reduce psychotic symptoms in schizophrenia [31].
More recently, Feifel et al. [32] as well as Pedersen et al.
[33] demonstrated that supra-physiological dosages of
intranasally administered OXT improves mindreading in
schizophrenia and reduces positive symptoms when admi-
nistered as an adjunct treatment to antipsychotic medica-
tion. An improvement of social behaviour has also been
reported in individuals with autistic spectrum disorders
[34]. Other studies have focused on alterations of OXT
concentrations in the cerebrospinal fluid (CSF) and serum.
An initial study found elevated CSF levels of OXT in
patients with schizophrenia compared to healthy controls,
which were higher in those patients receiving antipsycho-
tic treatment [35], whereas a follow-up study could not
confirm these results [36]. However, another study
demonstrated reduced OXT serum levels in patients with
schizophrenia, which additionally predicted their ability to
correctly identify facial emotions [37]. In trust-related
interpersonal interactions, healthy controls showed
increased plasma levels of OXT, whereas this effect was
absent in patients with schizophrenia [38]. Recently,
higher OXT serum levels in patients with schizophrenia
have been found to be associated with reduced symptom
severity compared to patients with lower OXT serum
levels [39].
In depression, serum OXT levels have been found to be
reduced, which included patients with bipolar depression
[40]. This reduction seems to correlate with symptom
severity [41], although another study suggests otherwise
[42]. Moreover, postmortem analyses indicate an increased
number of OXT-expressing neurons in the paraventricular
nucleus in depression, which may be associated with the
activation of the hypothalamic-pituitary-adrenal axis [43].
In anxiety disorders, OXT attenuated conditioned fear
responses and amygdala activity [44] to become similar to
the effects observed in psychologically healthy individuals
[45]. Somewhat inconsistent with these findings, OXT
plasma concentrations in social anxiety disorder were
positively correlated with symptom severity and dissatis-
faction with social relationships [46].
In a similar vein, women at risk of developing postpar-
tum depression had lower OXT plasma concentrations
than women who had no increased risk for postpartum
depression, and OXT serum levels in mid-gestation pre-
dicted postpartum depression symptoms [47]. OXT has
also been found to interact with the stress axis (particu-
larly cortisol) [48], and a stressful early life - for example,
through emotional abuse - have been linked to reduced
OXT levels in the CSF [49]. This finding may be particu-
larly relevant for borderline personality disorder, because
traumatization is prevalent in this disorder and leads to
reduced stress-tolerance and, hence, problems in emotion
regulation. A recent study reported that stress reactivity
improved in patients with borderline personality disorder
upon administration of OXT [50], which contrasts
with another study showing that trust and cooperation
decreased in patients with borderline personality disorder
as a function of anxious-ambivalent attachment [51]. This
is consistent with a recent study in healthy subjects, which
combined ‘compassion-focused imagery’ with OXT
administration. This study demonstrated that individuals
higher in self-criticism and lower in self-reassurance, social
Brüne BMC Medicine 2012, 10:38
http://www.biomedcentral.com/1741-7015/10/38
Page 3 of 9
safeness and attachment security benefitted less from
OXT compared to securely attached participants who had
a more positive self-evaluative style [52].
Taken together, OXT seems to be involved in various
psychopathological conditions. However, the diversity of
findings regarding plasma or CSF levels of OXT as well
as effects of intranasal OXT suggests a role for gene-
environment interactions that is as yet not fully under-
stood. Accordingly, the next section explores potential
links between a polymorphic variation of OXTR
(rs2254298), social behaviour, attachment and anatomi-
cal correlates of social cognition.
Polymorphic variation of the oxytocin receptor coding
gene and vulnerability to disorder
Recent studies have addressed the genetic variation of dif-
ferent loci within OXTR and their potential role in psycho-
pathological conditions (reviewed in [21]). The human
OXTR is a peptide comprising 389 amino acids. OXTR is
located on the short arm of chromosome 3 (3p25) and has
three introns and four exons. About 30 SNPs have been
localized in the OXTR region, most of which are located in
the intron sections [53].
On a MEDLINE survey using ‘oxytocin receptor’ and
‘polymorphism’ as key words, 11 matches were retrieved
for the SNP rs2254298. This SNP is situated in the third
intron of OXTR. Comparative genetics suggest that a
mutation replacing guanine (G) by adenine (A) has taken
place at some point during human evolution. Since the A
allele is absent in other primates, it can be concluded
that G is ancestral to A. Population genetics indicate that
the frequency of the A allele differs widely between ethni-
cities. For example, in samples of European ancestry the
A allele is quite uncommon, with the vast majority of
individuals being homozygous for the G allele. In Asian
populations, the frequency of the A allele is much higher,
and around just 40% to 50% are GG carriers [54]. This
difference in allele frequency needs to be kept in mind
when comparing studies in different populations.
Several studies have examined the link of allelic variation
of rs2254298 with psychopathological conditions. For
example, the A allele has been linked to autism in a
Chinese [55] and in a Japanese sample [56], but not in
Caucasians [57]. Instead, in the latter study the G allele
was associated with a higher risk for autism, a finding that
is consistent with the association of a five-locus haplotype
containing the rs2254298 SNP with autism in an Israeli
sample [58].
With regard to emotion regulation and affective disor-
ders, a haplotype block of seven SNPs containing
rs2254298G was associated with lower scores of depres-
sive affect in a Japanese sample of non-clinical individuals
[59]. That is, individuals carrying at least one A allele had
higher scores of depressive affect as measured using a
semi-structured interview to assess one’s temperament
(TEMPS-A). This finding is consistent, though not iden-
tical to, a study by Lucht et al. [60], who reported that
carriers of rs2254298G had (at trend level) higher values
of positive affect compared to A carriers, as examined
using the Positive and Negative Affect Schedule, an
instrument that, unlike the TEMPS-A, refers to one’s
current mood, rather than temperament as a personality
trait. Conversely, Costa et al. [61] reported that, within a
clinical sample of Italian patients with unipolar or bipolar
depression, carriers who were homozygous for rs2254298G
(as opposed to GA or AA carriers) were over-represented
in the group of patients with unipolar, but not bipolar,
depression. In addition, with respect to attachment factors,
GG carriers rated relationships significantly more often as
secondary on the Attachment Style Questionnaire than GA
or AA carriers. This finding suggests that an avoidant
attachment style is more common in a clinical sample of
patients with unipolar depression carrying the G allele of
the rs2254298 SNP [61]. Interestingly, a recent study
showed that the attachment style in healthy children was
differentially associated with the presence or absence of an
A allele according to the children’s ethnicity. That is, the
presence of at least one A allele of the rs2254298 SNP was
associated with a significantly higher rate of secure attach-
ment than in GG carriers. However, this effect was
restricted to non-Caucasian children, whereas no such
effect was found in Caucasian children [62].
Since the aforementioned studies have not addressed
gene-environment interactions directly, it is difficult to
judge the extent to which one’s experience of early rela-
tionships (as revealed by attachment style) may or may
not interact with the development of clinical symptoms.
Thompson et al. [63] have demonstrated, however, that
such a link might exist with respect to rs2254298. In a
sample of nonclinical adolescent girls of mixed ethnic
background, aged between nine and fourteen years, they
found that girls carrying the AG genotype reported higher
levels of depressive symptoms, greater social anxiety and
physical symptoms of anxiety when having experienced
early adversity as compared to GG carriers (the AA geno-
type was too rare, and thus excluded from the analysis). In
this study, early adversity was defined by a history of
maternal depression, that is, mothers who had at least two
depressive episodes during their daughters’ lifetime,
whereas no early adversity was defined by the absence of
maternal depression. Put another way, there is some evi-
dence to suggest that the presence of an A allele of the
rs2254298 SNP may confer increased risk of developing
symptoms of anxiety if associated with early adversity, but
at present there is no clear evidence for lower than
expected rates of anxiety or depression in individuals with
an A allele under favourable early environmental condi-
tions. However, a closer inspection of Figure 1 in that
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article [63] suggests that the presence of an A allele in the
absence of early adversity was associated with lower levels
of depressive symptoms and lower social anxiety scores as
compared to GG genotype carriers who scored higher on
depressive symptoms and social anxiety (but not separa-
tion anxiety and physical symptoms of anxiety), regardless
of whether or not the GG carriers were exposed to early
adversity. This suggests that the GG genotype carriers
were less responsive to environmental contingencies as
regards the development of depressive symptoms and
social anxiety compared to the AG genotype carriers of
the rs2254298 SNP.
Consistent with this (tentative) interpretation, two ana-
tomical studies have revealed that carriers who possess at
least one A allele of the rs2254298 SNP exhibit greater
amygdalar volumes bilaterally compared to G carriers.
That is, GG genotype carriers have the smallest amygdala
volume, AA carriers the largest volume, with AG geno-
types lying in between. This association seems to be quite
robust, as it was found in two independent samples, one
of which comprised over 200 adult Japanese patients [64],
and the other comprising 51 adolescent Caucasian girls
[65], although the first of the aforementioned analyses has
been contested for possible methodological issues [66,67].
When viewing the A genotype of the rs2254298 SNP of
OXTR merely as a ‘risk allele’ for psychopathology, fore-
most autism, depression or anxiety disorders, it may
appear plausible that greater amygdala volumes represent
the anatomical correlate of greater vulnerability to one of
these psychopathological syndromes. An equally parsimo-
nious explanation is, however, that people who possess an
AA or AG genotype of rs2254298 are differentially suscep-
tible to develop a mental disorder only if the genotype is
associated with early adversity. Under favourable environ-
mental conditions, carriers of the AG or AA genotype
may in fact have a reduced risk of developing a psychiatric
disorder. Greater amygdala volume is, by no means, exclu-
sively linked to an enhanced risk for autism. On the con-
trary, a recent study reported that amygdala volume was
positively correlated with the size and complexity of one’s
social network. Specifically, the number of people in one’s
social network, as well as the number of different groups
these contacts belonged to, correlated significantly with
the volume of the left (and slightly less the right) amygdala
in younger and older psychologically healthy adults of
both sexes [68]. Taken together, these findings support the
view that diathesis-stress models of individual SNPs are
often just one side of the coin [12].
Discussion
The present article sought to explore the question
whether a polymorphic variation of the OXTR coding
gene could be associated with differential susceptibility to
psychiatric disorders. The basic premise was, in line with
Belsky’s theory [11], that genetic variation of the OXTR
that increase the vulnerability to psychopathology can
exert beneficial effects in the same domain when envir-
onmental contingencies are developmentally more posi-
tive. In an extension of the findings of Belsky et al.
supporting this idea [12], a second goal of this review was
to examine if such differential susceptibility to disorder
could be linked to neuroanatomical correlates of the
behavioural phenotype.
Consistent with the hypothesis that genetic variation at
OXTR is possibly associated with differential susceptibility,
carriers of the AG or AA genotype of the rs2254298 SNP
have been found to be more vulnerable to developing a
psychiatric condition, including autism [55-57], depression
and anxiety disorders [60,61,63], with profound differences
depending on ethnic background. In addition, variation at
this polymorphic site of OXTR seems to impact the devel-
opment of secure attachment [62], again with differences
according to ethnicity. None of the aforementioned studies
has taken into consideration potential gene-environment
interaction in terms of the effects of early adversity or the
absence thereof. To date, only one study gives at least
some clues how this could be conceptually relevant.
Thompson et al. demonstrated that the A versus G poly-
morphism of the rs2254298 SNP is differentially associated
with the presence or absence of early adverse experience
[63]. In this study, carriers with the AG genotype had a
greater risk of developing depressive symptoms and social
anxiety than GG genotype carriers when exposed to
adverse events during childhood, such as maternal
depression.
Indirect support for the differential susceptibility
hypothesis comes from two observations. One is that in
the study by Thompson et al. the differences between high
and low scores on psychopathology ratings were larger for
the AG genotype; that is, subjects who carried the AG
genotype and had no experience of maternal depression
had lower scores on depressive symptoms and social anxi-
ety than both the GG group with adversity and the GG
group without adversity [63]. By extrapolation, one could
assume that subjects carrying the AG genotype would
have scored even lower on measures of psychopathology if
exposed to thriving environmental conditions during
childhood. This conclusion is, at present, to some extent
speculative; however, it makes sense in light of a critical
remark by Belsky et al., suggesting that treating the
absence of adversity as the ‘good end’ of functioning may
lead to an under-detection of differential susceptibility
[12].
The other observation indirectly supporting the notion of
differential susceptibility pertains to anatomical differences
associated with OXTR polymorphic variation. The volume
of the amygdala has been found to increase in a ‘dose
dependent’ manner, depending on whether psychologically
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healthy individuals carry no, one or two A alleles of the
rs2254298 SNP [64,65], even though this seems to be influ-
enced by methodological issues, that is, whether one
chooses a voxel-based morphometric approach [66] or a
manual-tracing methodology [65,67].
With respect to psychopathology, a greater than average
volume of the amygdala has been found in children with
autism [69]. In light of the association of the A allele with
autism, at least in Asian populations [55,56], one could
therefore conclude that the A is ‘just’ a risk allele, hence
conferring increased vulnerability for psychiatric disorder.
When looking at adults, however, a different picture
emerges. In adults with autism, the amygdala size is
reduced, rather than increased [70]. Moreover, in psycho-
logically healthy adults, the amygdala volume is correlated
with social network size [68]. This speaks against a simple
relationship of amygdala size with autism that is mediated
by the OXTR genotype. Instead, it is conceivable that the
A load at the rs2254298 SNP of OXTRincreases one’s sus-
ceptibility to environmental conditions in ways that can
either produce an autistic phenotype if associated with
adverse environmental conditions, yet can also lead to
greater sociability (in other words, the opposite phenotype
in the same domain), if adversity is absent or environmen-
tal conditions beneficial. Notably, environmental adversity
does not necessarily mean that unfavourable effects on
development occur postnatally. It could well be the case
that adverse environmental contingencies strike much ear-
lier. For example, in the case of autism, Ronald et al. [71]
reported that prenatal maternal stress has a small, but sig-
nificant effect on the development of autistic traits in two-
year-old boys (reviewed in [72]).
From an evolutionary point of view, it is relevant in the
context of differential susceptibility that the A allele of
rs2254298 emerged as a mutation at some point during
human evolution, while the G allele is the ancestral variant
[54]. In addition, there are profound differences in the fre-
quency of A alleles between human populations. The
question whether or not these population differences are
due to founder effects, positive selection or a selective
sweep is unclear. In light of the putative association of
rs2254298A with amygdala size [64,65], and the link of
amygdala volume with social complexity [68], one can at
least not exclude positive selection at some point during
human evolution, provided that a larger social network
size has paid-off reproductively, which is in agreement
with the social brain hypothesis [16,17]. Consistent with
this interpretation, it is conceivable that the A allele of the
rs2254298 SNP of OXTR is similarly linked with develop-
mental plasticity as, for example, polymorphisms of the
DRD4 [7,8], where ethnic differences in frequency are
equally large.
The present article yields several limitations. One is that
the functionality of the SNP of OXTR is unknown, all the
more as it is located in a non-coding region of OXTR. Nor
is anything known about how polymorphic variation of
the OXTR or the interaction between genetic variation
and environment (epigenetic effects) translate into differ-
ential availability of OXT in the brain, an issue that may
account for the diverse findings regarding plasma or CSF
levels of OXT in psychopathological conditions. Moreover,
genetic variation at a single locus cannot be viewed upon
in isolation, since epistasis (interaction between two or
more genes) is prevalent. For example, with regard to
the differential susceptibility hypothesis, Belsky and Beaver
[73] recently reported that the individual load of
such alleles can exert additive effects on behaviour. They
examined five loci, namely the DRD2, DRD4, 5-HTTLPR,
dopamine transporter and MAO-A, in adolescents and
found that the more susceptibility alleles one possessed,
the greater an individual’s self-regulation abilities hinged
upon early environmental contingencies, such as the emo-
tional bond to one’s mother, for better or for worse. In
other words, the fewer susceptibility alleles a person was
endowed with, the less dependent self-regulation was on
individual genetics. Interestingly, this was statistically sig-
nificant only in the male participants, which could suggest
that men are perhaps more susceptible than women to
environmental influences as far as their self-regulatory
capacity is concerned [73].
Another important issue is that the interpretation of the
findings pertaining to rs2254298 cannot simply be general-
ized to other SNPs of OXTR. For example, the SNP
rs53576 of OXTR, which is also located in the third intron
and bears a G®A mutation, has been associated with
increased stress reactivity and lower empathy scores in
psychologically healthy patients of mixed ethnicity carry-
ing at least one A allele [74]. In contrast, another study
found that male GG carriers showed the highest sympa-
thetic cardiac reactivity to psychological stress compared
to A carriers (no such difference emerged in women) [75],
yet in another study displayed lower cortisol responses to
stress when receiving social support from their partner or
close friend than A carriers [76]. Moreover, individuals
with a GG or GA genotype were more likely to seek emo-
tional support when distressed than AA carriers. However,
this was evident only in North Americans, but not
Koreans where social support seeking is less common,
suggesting that culture modulates the interaction of stress-
related behaviour with genetic factors [77]. No conclusive
evidence has emerged with regard to attachment style (as
a potential clue to the quality of early experiences) and
rs53576 [24]. However, it has been reported that the SNP
rs53576 of OXTR makes an independent contribution to
lower levels of parental responsiveness to the needs of
young children, similar to the effects of the s-allele of the
HTTLPR, in a large sample of Caucasian mothers [78].
That is, the presence of at least one A allele of rs53576
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explained 3% of the variance of maternal sensitivity, with
the same amount being accounted for by the short seroto-
nin transporter allele, yet no interaction or potentiating
effect of the two SNPs was found. Taken together, in this
case the A allele of rs53576 seems to confer greater vul-
nerability to unfavourable psychological outcome, yet it is
unclear if this is compensated, and what the mechanism
could be that accounts for the observation that the A allele
is not selected against (but, instead, maintained at high fre-
quencies in some populations).
In any event, given the importance of OXT for sexual
behaviour, parturition and lactation in mammals, such
compensatory effects could well reside outside the nervous
system. However, surprisingly little research has examined
the impact of variation of the OXTR on reproduction. One
study suggests that OXT influences the micro-environment
surrounding the developing oocyte and is therefore
involved in regulating fertility and embryo development
[79]. Even more interestingly, another study involving over
1,000 male and 1,000 female participants reported that
polymorphic variation of the OXTR impacted the repro-
ductive behaviour of women. Specifically, Caucasian
women who carried the long version of the OXTR used
contraceptives less and had children at an earlier age com-
pared to women possessing the short variant (whereas
male sexual behaviour was influenced by variation of the
arginine-vasopressin receptor gene). Put another way,
women’s reproductive behaviour and life history traits were
influenced by variation of the OXTR [80]. Unfortunately,
as yet no information is available as regards rs2254298 on
sexual behaviour and reproduction.
Conclusions
Polymorphic variation at the OXTR is a candidate for dif-
ferential susceptibility to environmental contingencies,
which, if associated with adversity during early childhood
or even the prenatal period, may result in a greater risk of
developing psychopathologies such as autism. Conversely,
under thriving conditions the same variation may have
advantageous effects on an individual’s social network,
hence supporting the view that all genetic variation may
not unequivocally be linked to greater vulnerability but,
rather, to increased plasticity. With respect to variations at
OXTR, gene-environment interactions are poorly studied,
such that more information is warranted, especially con-
cerning the effects of positive environmental conditions
(for example, emotional warmth and acceptance) on neu-
rodevelopment, not just the absence of adversity [12].
Moreover, to date it is unclear how exactly polymorphic
variation at the OXTR translates into the actual availability
of OXT in the brain. Similarly, it is poorly understood how
variation of the OXTR interacts with cultural differences
and differences between male and female psychology.
Finally, examining the physiological effects of OXTR
polymorphisms on sexuality and reproductive behaviour
could broaden the picture of the functionality of the oxy-
tocinergic system.
In summary, this overview is one of the first that has
argued for an association of genetic plasticity with
both behavioural and neuroanatomical correlates of
gene-environment interaction. Even though more stu-
dies are needed to clarify several open questions, the
diathesis-stress model of psychopathological conditions
needs to be refined by anchoring clinical research on
gene-environment interaction in evolutionary theory
[81]. Such an approach may also be suitable to inform
research on gene-environment interaction in psychiatry
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